MEDD (Medical Imaging) Cyclically Adjusted Revenue per Share: $0.00 (As of Sep. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Medical Imaging Cyclically Adjusted Revenue per Share?

Medical Imaging MEDD Cyclically Adjusted Revenue per Share is $0.00 as of Sep. 2018.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medical Imaging's adjusted revenue per share for the three months ended in Sep. 2018 was $0.035. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Sep. 2018.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-14), Medical Imaging's current stock price is $1.0E-5. Medical Imaging's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2018 was $0.00. Medical Imaging's Cyclically Adjusted PS Ratio of today is .


Medical Imaging  (OTCPK:MEDD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medical Imaging Cyclically Adjusted Revenue per Share Related Terms


Medical Imaging Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medical Imaging's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Imaging Cyclically Adjusted Revenue per Share Chart

Medical Imaging Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medical Imaging Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MEDD vs TEAR, INVB, DCTH: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Medical Imaging's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Imaging Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medical Imaging's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medical Imaging's Cyclically Adjusted PS Ratio falls into.



Medical Imaging Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medical Imaging's adjusted Revenue per Share data for the three months ended in Sep. 2018 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2018 (Change)*Current CPI (Sep. 2018)
=0.035/252.4390*252.4390
=0.035

Current CPI (Sep. 2018) = 252.4390.

Medical Imaging Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200812 0.000 210.228 0.000
200903 0.009 212.709 0.011
200906 0.029 215.693 0.034
200909 0.034 215.969 0.040
200912 0.042 215.949 0.049
201003 0.039 217.631 0.045
201006 0.040 217.965 0.046
201009 0.044 218.439 0.051
201012 0.044 219.179 0.051
201103 0.050 223.467 0.056
201106 0.054 225.722 0.060
201109 0.053 226.889 0.059
201112 0.039 225.672 0.044
201203 0.045 229.392 0.050
201206 0.046 229.478 0.051
201209 0.047 231.407 0.051
201212 0.049 229.601 0.054
201303 0.056 232.773 0.061
201306 0.051 233.504 0.055
201309 0.056 234.149 0.060
201312 0.054 233.049 0.058
201403 0.051 236.293 0.054
201406 0.055 238.343 0.058
201409 0.053 238.031 0.056
201412 0.069 234.812 0.074
201503 0.076 236.119 0.081
201506 0.083 238.638 0.088
201509 0.069 237.945 0.073
201512 0.066 236.525 0.070
201603 0.076 238.132 0.081
201606 0.075 241.018 0.079
201609 0.071 241.428 0.074
201612 0.060 241.432 0.063
201703 0.069 243.801 0.071
201706 0.046 244.955 0.047
201709 0.045 246.819 0.046
201712 0.099 246.524 0.101
201803 0.054 249.554 0.055
201806 0.035 251.989 0.035
201809 0.035 252.439 0.035

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.00 mean?
Medical Imaging (MEDD) has a Cyclically Adjusted Revenue per Share of $0.00 as of Sep. 2018. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medical Imaging and its competitors.
Is Medical Imaging's Cyclically Adjusted Revenue per Share too high?
Medical Imaging's current Cyclically Adjusted Revenue per Share is $0.00.
How does Medical Imaging's Cyclically Adjusted Revenue per Share compare to TEAR and INVB?
Medical Imaging's Cyclically Adjusted Revenue per Share of $0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medical Imaging and its competitors. Medical Imaging's current Cyclically Adjusted Revenue per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Imaging stock overvalued right now?
Medical Imaging (MEDD) has a current Cyclically Adjusted Revenue per Share of $0.00. The current Cyclically Adjusted Revenue per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medical Imaging (MEDD), the current Cyclically Adjusted Revenue per Share is $0.00 as of Sep. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medical Imaging Business Description

Address 848 N Rainbow Boulevard, No. 2494, Las Vegas, NV, USA, 89107
Medical Imaging Corp is a United States-based healthcare services company focused on the acquisition of existing full-service imaging clinics. Through its subsidiaries, the firm provides medical diagnostic imaging services. The services provided include magnetic resonance imaging, CT scans, ultrasound, X-ray, and others. The group has operations in the United States and Canada. The organization generates revenue from the medical scans services and teleradiology services, of which medical scans services contributes the maximum to the revenue.